Johnson & Johnson (JNJ) Cash from Financing Activities (2009 - 2026)

Johnson & Johnson has disclosed Cash from Financing Activities across 18 years of filings, most recently posting $530.0 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $530.0 million, down 94.91% year-over-year; the trailing twelve-month figure through Mar 2026 was -$15.4 billion (down 328.81% YoY), and the FY2025 annual result was -$5.5 billion, down 76.85% from the prior year.
• Cash from Financing Activities came in at $530.0 million for Q1 2026 at Johnson & Johnson, up from -$1.4 billion in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $10.4 billion in Q1 2025 to a low of -$11.3 billion in Q4 2023.
• The 5-year median for Cash from Financing Activities is -$1.4 billion (2025), against an average of -$1.8 billion.
• Across the five-year window, Cash from Financing Activities tumbled 367.53% in 2023 and surged 1808.79% in 2025, its largest moves.
• Johnson & Johnson's Cash from Financing Activities stood at -$4.4 billion in 2022, then retreated by 6.16% to -$4.7 billion in 2023, then soared by 71.21% to -$1.3 billion in 2024, then fell by 2.16% to -$1.4 billion in 2025, then jumped by 138.71% to $530.0 million in 2026.
• The last three Cash from Financing Activities figures came in at $530.0 million (Q1 2026), -$1.4 billion (Q4 2025), and -$8.9 billion (Q3 2025), per Business Quant data.